How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis

Monoclonal antibodies targeting epidermal growth factor receptor (EGFR) or vascular endothelial growth factor (VEGF) have demonstrated efficacy with chemotherapy (CT) as second line treatment for metastatic colorectal cancer (mCRC). The right sequence of the treatments in all RAS (KRAS/NRAS) wild ty...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Galvano, Antonio, Incorvaia, Lorena, Badalamenti, Giuseppe, Rizzo, Sergio, Guarini, Aurelia, Cusenza, Stefania, Castellana, Luisa, Barraco, Nadia, Calò, Valentina, Cutaia, Sofia, Currò, Giuseppe, Silvestris, Nicola, Beretta, Giordano Domenico, Bazan, Viviana, Russo, Antonio
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721481/
https://ncbi.nlm.nih.gov/pubmed/31443300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081189
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares